Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma Treated with Combined Modality Treatment Including Surgical Resection: A Pilot Study

Purpose: To evaluate the overall survival of patients with oligometastatic pancreatic ductal adenocarcinoma (PDAC; metastatic tumor <4 cm, ≤2 metastatic tumors total) receiving neoadjuvant therapy, metastasectomy and/or ablation, and primary tumor resection. Methods: We performed a case–control s...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandel, Pujan, Wallace, Michael B., Stauffer, John, Bolan, Candice, Raimondo, Massimo, Woodward, Timothy A., Gomez, Victoria, Ritter, Ashton W., Asbun, Horacio, Mody, Kabir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319614/
https://www.ncbi.nlm.nih.gov/pubmed/30631861
http://dx.doi.org/10.1089/pancan.2018.0011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319614/
https://www.ncbi.nlm.nih.gov/pubmed/30631861
http://dx.doi.org/10.1089/pancan.2018.0011

Ejemplares similares